Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.
Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- Check4 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a Locations section detailing study sites across multiple states, countries, and cities, broadening enrollment sites.SummaryDifference3%
- Check54 days agoChange DetectedPublications section now states that PubMed-sourced publications are automatically populated and may not all relate to the study, and the revision version updated to v3.3.2 (replacing v3.2.0).SummaryDifference0.4%
- Check61 days agoChange DetectedDeleted the boilerplate government funding/operating status notice from the page. Core study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.1%
- Check82 days agoChange DetectedThe screenshots show the same Study Details page with only minor visual/layout differences; no core content such as study design, outcomes, or eligibility criteria appears to have changed.SummaryDifference0.1%
- Check104 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%
Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.